ArticleImmunity, inflammation and disease2026
Integrated Analysis of the Immune Infiltration Pattern and Novel Diagnostic Biomarkers in Septic Cardiomyopathy.
Article in Immunity, inflammation and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrated Analysis of the Immune Infiltration Pattern and Novel Diagnostic Biomarkers in Septic Cardiomyopathy.Immunity, inflammation and disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeIn this study, various informatics analyses were employed to identify the hub genes associated with septic cardiomyopathy (SCM) onset and investigate their immune infiltration status.
methodsHigh-throughput sequencing data of myocardial tissue samples from mice with SCM were obtained from the GEO database and our previously published articles. The Limma and weighted gene co-expression network analysis (WGCNA) packages were used to identify the hub genes associated with SCM onset. GSEA and the DAVID database were employed for gene enrichment analysis. Additionally, the CIBERSORT database was used to analyze the immune infiltration in SCM. Finally, the multiMiR package was used to analyze the microRNAs acting as ceRNAs for the hub genes. Receiver operating characteristic (ROC) curves and Mendelian randomization analysis were used to evaluate the predictive value of hub genes for SCM.
resultsThe SCM group included nine samples, while the control group included ten samples. SCM upregulated 15 genes and downregulated 7. Mt1 and Actc1 were the most significantly upregulated and downregulated, respectively. GO analysis indicated that the most significantly enriched biological process was "response to bacterium," and the most enriched signaling pathway was "mineral absorption." Immunoinfiltration analysis revealed decreased T cells CD4 naive, B cells naive, resting mast cells, and M2 macrophage infiltration in the hearts of SCM mice. WGCNA and Limma package analyses identified Clu, Igf1, and Trp53 as hub genes associated with SCM onset. The ROC curves demonstrated a strong correlation and predictive value for Trp53, Igf1, and Clu in the SCM. Moreover, Clu and Igf1 demonstrated predictive values for SCM using Mendelian randomization analysis from the IEU database. Eleven miRNAs formed a ceRNA network with these hub genes.
conclusionIn summary, our results implicated Igf1 and Clu as the potential candidates involved in SCM pathogenesis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.